Skin neoplasias including cutaneous lymphoma, melanoma, and others: unapproved treatments or indications.
Abel
E A
EA
Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000592:standards; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000592:standards; D017277:Drug Approval; D005260:Female; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy*; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D003879:Dermatologic Agents